Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial
Sign Up to like & getrecommendations! Published in 2022 at "Digestive Diseases"
DOI: 10.1159/000527460
Abstract: Background: The therapeutic goal of clinical remission in patients with moderate to severe ulcerative colitis (UC) is achieved after biological therapy only in 16–39%. Individualization of therapeutic intervention would benefit from prediction of early response.… read more here.
Keywords: clinical response; therapy; response week; week ... See more keywords